common.study.topics.clinical

Postpartum Low-Dose Aspirin and Preeclampsia

common.study.values.description

Postpartum Low-Dose Aspirin and Preeclampsia

The purpose of this research study is to find out whether women with severe preeclampsia taking low-dose aspirin (LDA) for 3 weeks post-delivery will experience an improvement in endothelial function (measured as flow-mediated dilation - FMD) and severity of disease, as the effects of preeclampsia can persist postpartum. Women diagnosed with severe preeclampsia prior to delivery will be enrolled and randomized to receive either low-dose aspirin (81mg) or placebo to take daily for up to 3 weeks post-delivery.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - Aspirin

Low dose aspirin, 81mg tablets, PO

Drug - Placebo oral capsule

Placebo oral capsule, PO

participant.views.study.view.additional

participant.views.study.view.scientific-title

Low-Dose Aspirin in the Postpartum Period and Endothelial Function in Patients With Preeclampsia

common.study.values.clinical-trial-id

NCT03667326

participant.views.study.view.id

dL9ZAe